TICAGRELOR
- Product NDC
- 50268-826
- 11-digit product format
- 502680826
- Labeler code
- 50268
- Product ID
- 50268-826_42501349-0107-5655-e063-6394a90a9b0c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- TICAGRELOR
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA208596
- Marketing category
- ANDA
- Marketing start
- 2025-10-29
- Substance
- TICAGRELOR
- Active strength
- 90 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TICAGRELOR
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TICAGRELOR | 90 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | GLH0314RVC |
| Rxcui | 1116635 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50268-826-01 | TICAGRELOR | 100 in 1 BOX | TABLET | 100 | | 1 |
| 50268-826-11 | TICAGRELOR | 1 in 1 BLISTER PACK | TABLET | 1 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50268-826-01 | 50268082601 | 100 BLISTER PACK in 1 BOX (50268-826-01) / 1 TABLET in 1 BLISTER PACK (50268-826-11) | 100 blister pack | 2025-10-29 | No | No | Historical |
| 50268-826-11 | 50268082611 | 1 in 1 BLISTER PACK | | | | | Historical |